trial
as of 2026-07-01Mechanisms of Sulforaphane Supplementation in Alleviating Negative Symptoms and Cognitive Impairment in Schizophrenia
NCTId NCT07652866
at a glance
— · Not Yet Recruiting
Enrollment 60 (estimated)
Sponsored by Second Xiangya Hospital of Central South University
Primary completion 2028-12-31
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Not Yet Recruiting
Enrollment
60 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2026-06-02
Primary completion
2028-12-31
Eligibility
ALL · 12 Years · 45 Years
Interventions & indications
Drugs
Indications
Sponsors
Sites
1 total
Changsha, China
Facts & assertions
4 sourced
Enrollment
60
Phase
NA
Primary Completion Date
2028-12-31
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
drug
lead_sponsor
indication
indication
indication